標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
Regenerative medicine
#
Regenerative medicine
About 6 search results
Sort by Date
Business
PR Newswire
Creative Life Science Advances PIC/S GMP-Compliant Cell Therapy Materials and Manufacturing Platform
Targets Japan and Singapore as Part of Broader Asia Expansion
PR Newswire
2026-07-17 14:12
Creative Life Science
Regenerative medicine
cell therapy
Business
PR Newswire
MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis
U.S. Phase III Trial Expands Clinical Investigation of Stem Cell Therapy for Knee Cartilage Defects
PR Newswire
2026-07-08 10:43
MEDIPOST
stem cell therapy
knee osteoarthritis
Business
PR Newswire
PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view
PR Newswire
2026-07-01 13:38
PharmaResearch
REJURAN Cosmetics
CG USA
Business
PR Newswire
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan
PR Newswire
2026-06-24 21:30
Stemchymal
REPROCELL
Spinocerebellar Ataxia
Business
PR Newswire
UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson's Therapy
SHANGHAI
PR Newswire
2026-06-24 14:04
UniXell Biotechnology
UX-DA003
Parkinson's disease
Business
PR Newswire
Doctors at Omotesando Helene Clinic Publish New Study on Long-Term Safety Surveillance Following High-Dose Intravenous MSC Administration
Continuing clinical data analysis and academic publication in regenerative medicine and ATMP as the Tokyo clinical hub within Helene Bio Group
PR Newswire
2026-05-29 13:50
Mesenchymal Stem Cell
Regenerative medicine
Omotesando Helene Clinic